HLTH Europe Startup Finalist
Delighted to be named a 2025 finalist in the HLTH Europe Startup Pitch, sponsored by Haleon! Honoured to share the stage with some of the most innovative healthtech startups in Europe. See you in Amsterdam. 🇳🇱
Naomi Aduroja joins as a Roivant Social Ventures Global Access Fellow
💥 A warm welcome to Naomi Aduroja who joins us as a Roivant Social Ventures Global Access Fellow this summer. Currently preparing for her third year in the prestigious PharmD program at UNC Eshelman School of Pharmacy – we’re delighted to have Naomi support various R&D projects leaning on her experience including from across pharmacy …
ACOG Clinical & Scientific Meeting in Minneapolis
We’re delighted to be in Minneapolis for the American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting. From May 16th-18th, we’ll be ready to connect, collaborate, and showcase our Callavid® vaginal drug delivery innovation at the largest meeting of obstetricians and gynecologists in the US. This is an exciting opportunity to discuss …
Discover CLCC’s B Corp Impact Report
We believe that true success in business must be measured not just by commercial milestones, but by the positive impact we create. To us, being a B Corp is more than a certification – it’s a daily commitment to balancing people, planet, profit, and purpose. B Lab’s rigorous standards provide a clear framework for accountability …
CLCC awarded £1m NIHR funding to address threatened miscarriage
Pioneering technology to address threatened miscarriage secures £1 million funding and moves towards clinical trials • Scientists developing a pioneering device designed to address threatened miscarriage have secured £1 million in NIHR funding to begin clinical trials • Designed to deliver vital doses of progesterone, the Callavid® device stands to help over 150,000 women each …
Int’l Women’s Day
A slightly belated nod to International Women’s Day (as we’ve just taken this 📸 )— but still just in time for Women’s History Month. I want to take a moment to share how incredibly grateful I am to work alongside such a brilliant, dedicated, and inspiring group of women at Calla Lily Clinical Care 🔬 It’s …
China & Manufacturing Patent Grants
We’ve achieved some exciting IP milestones for Calla Lily Clinical Care; making strong progress in building a robust IP strategy and IP portfolio to protect and advance our innovations in women’s health. 💥 China Patent Grant for our Drug Delivery Device 🌏 At long last, one of our vaginal drug delivery applications in China has …
SXSW Conference in Austin
Calla Lily Clinical Care is excited to be in Austin for SXSW! 🇺🇲 This dynamic conference & festival celebrates the convergence of tech, film, music, and culture while empowering creatives to achieve their goals. We’re excited to connect with like-minded innovators across these different industries who share our commitment to elevating women’s health. If you’re …
EMBAs from MIT Sloan boosting CLCC’s US strategy
We’re delighted to welcome Jaren, Humaira and TJ to our offices – three dynamic Executive MBAs from MIT Sloan School of Management who are working closely with Lara, myself and the rest of our Calla Lily Clinical Care leadership team over the next 4 months. As part of MIT Sloan’s Global Organizations action learning lab …
R&D team excellence
A shout-out to our incredible Calla Lily Clinical Care Team. With some key deadlines approaching, our R&D team has been working with relentless dedication, precision, and an unwavering commitment to excellence.💥 This is where the real ✨magic happens at our firm – brilliant minds, working hard, driven by purpose, coming together to push the boundaries …